amylin cagrilintide news Combined GLP-1/amylin analog bests monotherapy for HbA1c drop, weight loss in diabetes Eloralintide Lilly's Amylin Agonist Outperforms
Eloralintide Lilly's Amylin Agonist Outperforms Novo's Cagrilintide at 48 Weeks Structural and mechanistic insights into dual activation of cagrilintide in amylin and calcitonin receptors Acta Pharmacologica Sinica Amylin Commands Weight Loss Attention as Industry Anticipates Novo's Phase III CagriSema Readout BioSpace Cagrilintide is a long acting amylin analog that regulates appetite, gastric emptying, and glucagon secretion to treat obesity and related metabolic disorders. There are 2 pathways cagrilintide works:
Pay in 4 interest-free payments of $5.85 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7


